News
Under the Vevye Access for All program, patients with a Klarity-C prescription can switch to Vevye for $59 per bottle.
Verastem, Inc.'s priority PDUFA date for avutometinib + defactinib in LGSOC set for June 2025; explore future data updates. Click for my VSTM stock update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback